Open an account

GoodRx Holdings

GDRX · NASDAQ

$3.52+$0.15 (+4.45%)TodayMarket closed ·
Prev close $3.37

About GDRX

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 697 full-time employees. The company went IPO on 2020-09-23. The firm connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The firm's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The firm partners with pharma manufacturers to advertise and integrate their affordable solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.

Employees
697
Headquarters
Santa Monica, California
Listed
Sep 23, 2020
Sector
Health Care
Industry
Health Care Technology
Website
investors.goodrx.com

GDRX key statistics

Market cap
1.15B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
828.84K
Volume
2.38M
Open price
$3.38
High today
$3.54
Low today
$3.38
52 Week high
$4.05
52 Week low
$1.77

GoodRx Holdings (GDRX) at a glance

GoodRx Holdings (GDRX) last traded at $3.52, with a market cap of 1.15B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.38 and $3.54. The current price is 4.1% above the day's low and 0.4% below its high.

Volume so far is 2.38M shares, above the average of 828.84K shares a day.

Over the past year GoodRx Holdings has ranged from $1.77 to $4.05, and now sits 77% of the way up that range.

GoodRx Holdings met or beat analyst EPS estimates in 0 of the last 8 quarters. In Q2 FY26 it reported $0.08 per share against an estimate of $0.0808.

The average analyst price target is $4.03, 14.5% above the current price, from 9 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

33%of 9 analyst ratings say Buy
  • Buy33.3%
  • Hold55.6%
  • Sell11.1%
Price target · 14 analystsAvg $4.03
Low
$2.68
Now
$3.52
High
$5.25

GDRX earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 8 quarters.

  1. Q3 FY24: reported $0.08 per share against an estimate of $0.088
  2. Q4 FY24: reported $0.09 per share against an estimate of $0.0985
  3. Q1 FY25: reported $0.09 per share against an estimate of $0.0969
  4. Q2 FY25: reported $0.09 per share against an estimate of $0.1007
  5. Q3 FY25: reported $0.08 per share against an estimate of $0.0924
  6. Q4 FY25: reported $0.09 per share against an estimate of $0.0934
  7. Q1 FY26: reported $0.07 per share against an estimate of $0.0734
  8. Q2 FY26: reported $0.08 per share against an estimate of $0.0808

GDRX news

  • Press releaseBusiness Wire

    From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

  • Press releaseBusiness Wire

    GoodRx Reports Second Quarter 2026 Results

  • Press releaseBusiness Wire

    GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

  • Press releaseBusiness Wire

    GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

  • Press releaseBusiness Wire

    GoodRx Reports First Quarter 2026 Results

  • Press releaseBusiness Wire

    GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients

  • Press releaseBusiness Wire

    GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call

  • Vandana Singh

    GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market

Similar companies

Companies in the same industry as GoodRx Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.